Skip banner and top navigation
NHLBI Logo and Link
National Heart, Lung, and Blood Institute: People, Science, Health
 HOME  SITE INDEX  CONTACT US
  
  Patient Recruitment - Lung Diseases
TIPS     ADVANCED SEARCH
 

Research Studies        
Cystic Fibrosis Research Study   Pulmonary Fibrosis Research Evaluation Study   Longitudinal Observational Study of Severe Asthma  
Lymphangioleiomyomatosis (LAM) and Tuberous Sclerosis Research Study   Pulmonary Hypertension - Research Screening Study   Genetics of Asthma Research Study  
Lymphangioleiomyomatosis (LAM) Treatment Research Study   Pulmonary Sarcoidosis Treatment Trial   Sample Collections from the Airways of Asthmatic Patients
Familial Pulmonary Fibrosis Research Evaluation Study   Severe Asthma Pioglitazone Clinical Trial  

Cystic Fibrosis Research Study

Cystic Fibrosis Research Study

If you have been diagnosed with cystic fibrosis (CF), you may be eligible to participate in a research study at the NIH Clinical Center. The purpose of this research is to improve understanding of CF. Those with CF 9 years of age and older will undergo a pulmonary evaluation at the NIH Clinical Center in Bethesda, MD.

There is no cost to you for travel or medical testing, and should you wish, information from your evaluation will be provided for your physicians.

For further information, please contact our research coordinator at the toll free telephone:1-800-411-1222; e-mail: LungStudy@nhlbi.nih.gov.
 
Email This Study To A Friend       View/Print PDF Version Of This Study

Protocol Information

Disease and Treatment Information

Support Groups
 

 

Lymphangioleiomyomatosis (LAM) Research Study

Lymphangioleiomyomatosis (LAM) and Tuberous Sclerosis Research Study

If you have been diagnosed with Lymphangioleiomyomatosis (or LAM) or with tuberous sclerosis complex (TSC), you may be eligible to participate in a research study at the NIH Clinical Center. The purpose of this research study is to improve our understanding of LAM and TSC. Eligible patients undergo a comprehensive pulmonary evaluation at the Clinical Center in Bethesda, MD.

There is no cost to you for travel or medical testing and, should you wish, information from your evaluation will be provided for your physicians.

For further information, please contact our research coordinator at toll free telephone: 1-877-NIH-LUNG (1-877-644-5864), extension 3, email: LungStudy@nhlbi.nih.gov.
 
Email This Study To A Friend       View/Print PDF Version Of This Study

Protocol Information

Disease and Treatment Information
 

 

Lymphangioleiomyomatosis (LAM) Research Study

Lymphangioleiomyomatosis (LAM) Treatment Research Study

If you have been diagnosed with lymphangioleiomyomatosis and have developed fluid in the lungs (chylous effusions), you may be eligible to participate in our research study. If eligible, you will undergo a comprehensive pulmonary and medical evaluation at the Clinical Center in Bethesda, MD. The purpose of this study is to test the effectiveness of a medication called octreotide on symptoms and chylous effusions. Octreotide is a medicine, that in other studies was helpful in reducing chylous ascites, effusions and other disorders associated with lymphatic flow.

There is no cost to you for travel or medical testing, and should you wish, information from your evaluation will be provided for your physicians.

For further information, please contact our research coordinator at toll free telephone: 1-877-NIH-LUNG (1-877-644-5864),
extension 3, or e-mail:LungStudy@nhlbi.nih.gov
 
Email This Study To A Friend       View/Print PDF Version Of This Study

Protocol Information

Disease and Treatment Information
 

 

Pulmonary Fibrosis Research Study

Familial Pulmonary Fibrosis Research Evaluation Study

If you or two of your relatives have been diagnosed with familial pulmonary fibrosis, you and your relatives may be eligible to participate in a research study at NIH Clinical Center. The purpose of this research is to improve the understanding of the natural history of this disease and its underlying cause(s). Eligible volunteers undergo a comprehensive medical and pulmonary evaluation at NIH Clinical Center in Bethesda, MD.

There is no cost for to you for travel or medical testing, and should you wish, information from your evaluation will be provided for your physicians.

For further information, please contact our research coordinator at toll free telephone: 1-877-NIH-LUNG (1-877-644-5864), extension 1; e-mail: LungStudy@nhlbi.nih.gov.
 
Email This Study To A Friend       View/Print PDF Version Of This Study

Protocol Information

Disease and Treatment Information

Support Groups
 

 

Pulmonary Fibrosis Research Study

Pulmonary Fibrosis Research Evaluation Study

If you have been diagnosed with pulmonary fibrosis (or IPF), you may be eligible to participate in a research study at NIH Clinical Center. The purpose of this research is to improve the understanding of the natural history of pulmonary fibrosis and its underlying cause(s). Eligible volunteers undergo a comprehensive medical and pulmonary evaluation at the NIH Clinical Center in Bethesda, MD.

There is no cost to you for travel or medical testing, and should you wish, information from your evaluation will be provided for your physicians.

For further information, please contact our research coordinator at toll free telephone: 1-877-NIH-LUNG (1-877-644-5864), extension 1; e-mail: LungStudy@nhlbi.nih.gov.
 
Email This Study To A Friend       View/Print PDF Version Of This Study

Protocol Information

Disease and Treatment Information

Support Groups
 

 

Pulmonary Hypertension Research Study

Pulmonary Hypertension - Research Screening Study

Researchers at the NIH invite you to take part in a study that will help us learn how often people with sickle cell anemia develop a complication called pulmonary hypertension. Pulmonary hypertension is a serious disease in which blood pressure in the artery to the lungs is elevated.

You are eligible to participate if you are 18 years of age or older and have sickle cell disease. This study consists of an initial evaluation (including a physical exam, blood tests, and an echocardiogram), a follow-up telephone interview every year after the initial echocardiogram, and a repeat echocardiogram and blood tests approximately two years after the first. There is no cost to participate.

Please contact the study coordinator at 301-435-2345 for more information or email VascularStudy@nhlbi.nih.gov
 
Email This Study To A Friend       View/Print PDF Version Of This Study

Protocol Information

Disease and Treatment Information

Support Groups
 

 

Sarcoidosis Research Study

Pulmonary Sarcoidosis Treatment Trial

If you have been diagnosed with sarcoidosis of the lung, you may be eligible to participate in a study at the NIH Clinical Center. The purpose of this study is to determine if a widely used cholesterol-lowering agent can decrease the amount of prednisone (steroids) required to manage your illness. Eligible patients will receive a comprehensive evaluation at the Clinical Center in Bethesda, Maryland.

There is no cost to you for travel or medical testing.

For further information, please contact our research coordinator, toll free, at 1-877-NIH-LUNG (1-877-644-5864), e-mail: LungStudy@nhlbi.nih.gov, or you may call Sandra MacDonald, RN at 301-451-4899. Alternatively, you may reach the NIH Patient Recruitment and Public Liaison Office via TTY 1-866-411-1010.

 
Email This Study To A Friend       View/Print PDF Version Of This Study

Protocol Information

Disease and Treatment Information

Support Groups
 

 

Asthma Research Study

Severe Asthma Pioglitazone Clinical Trial

Patients with severe asthma may be eligible to participate in a study at the NIH Clinical Research Center. The purpose of this study is to determine if a widely used agent for diabetes can improve asthma. Eligible patients will receive a comprehensive evaluation at the Clinical Research Center in Bethesda, Maryland. There is no cost for participating in the study.
For further information, please contact our research coordinator, toll free, at 1-877-NIH-LUNG (1-877-644-5864), extension 2 or via e-mail at LungStudy@nhlbi.nih.gov. You may also contact the NIH Patient Recruitment and Public Liaison Office via TTY 1-866-411-1010.
 
Email This Study To A Friend       View/Print PDF Version Of This Study

Protocol Information

Disease and Treatment Information
 

 

Asthma Research Study

Longitudinal Observational Study of Severe Asthma

Patients with severe asthma may be eligible to participate in a study at the NIH Clinical Research Center. The purpose of this study is to learn more about the factors that cause severe asthma. Eligible patients will receive a comprehensive evaluation at the Clinical Research Center in Bethesda, Maryland. There is no cost for participating in the study. For further information, please contact our research coordinator, toll free, at 1-877-NIH-LUNG (1-877-644-5864), extension 2 or via e-mail at LungStudy@nhlbi.nih.gov. You may also contact the NIH Patient Recruitment and Public Liaison Office via TTY 1-866-411-1010.
 
Email This Study To A Friend       View/Print PDF Version Of This Study

Protocol Information

Disease and Treatment Information
 

 

Asthma Research Study

Genetics of Asthma Research Study

If you have been diagnosed with asthma and allergies, you may be able to participate in an asthma genetics research study at the NIH Clinical Center. The purpose of this research is to identify genes that may be involved in the development or severity of asthma.

Eligible volunteers will undergo a comprehensive medical and pulmonary evaluation at the NIH Clinical Center in Bethesda, MD. There is no cost to you for medical testing and evaluation. You will receive monetary compensation for participating in the study.

For further information, please contact our research coordinator toll free at 1-877-NIH-LUNG (1-877-644-5864), extension 2; email: LungStudy@nhlbi.nih.gov
 
Email This Study To A Friend       View/Print PDF Version Of This Study

Protocol Information

Disease and Treatment Information
 

 

Asthma Research Study

Sample Collections from the Airways of Asthmatic Patients

Patients with asthma may be able to participate in a sample collection study at the NIH Clinical Center. This study involves a procedure called a fiberoptic bronchoscopy in which cells and fluids are collected from the airways using a pencil-thin tube that is passed into the lungs. The purpose of this research is to identify factors that may cause airway inflammation in patients with asthma.
Eligible patients will receive a comprehensive evaluation at the NIH Clinical Research Center in Bethesda, Maryland. There is no cost to you for the medical evaluation. You will receive monetary compensation for participating in the study.
For further information, please contact our research coordinator, toll-free, at 1-877-NIH-LUNG (1-877-644-5864), extension 2 or via email at LungStudy@nhlbi.nih.gov. You may also contact the NIH Patient Recruitment and Public Liaison Office via TTY 1-866-411-1010.
 
Email This Study To A Friend       View/Print PDF Version Of This Study

Protocol Information

Disease and Treatment Information
 

 
 
Spacer

NHLBI HOME · ACCESSIBILITY INFORMATION · NHLBI AT THE CLINICAL CENTER · PRIVACY STATEMENT · SUPPORTED BROWSERS · WEB TECHNICAL CONTACT· v1.2.0.1